This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Independent Clinical Research Confirms Clinical Efficacy And Cost-Effectiveness Of The SurgiCount Safety-Sponge® System

IRVINE, Calif. and DUBLIN, Ohio, Jan. 18, 2011 /PRNewswire/ -- Results of a multi-year, independent clinical research study on retained surgical sponges published in the February edition of The Joint Commission Journal on Quality and Patient Safety show that the institution implementing the SurgiCount Safety-Sponge® System eliminated the occurrence of retained surgical sponges and the costs associated with these preventable surgical errors.  

The peer-reviewed publication details two, randomized, controlled trials conducted at a high-volume surgical practice, the subsequent implementation of the Safety-Sponge® System across all of the 128 operating rooms at the affiliated institution and a comprehensive evaluation of the solution after 18 months of use. The evaluation considered variables including system effectiveness on reducing retained surgical sponges, efficiency, impact on operative time, ergonomics and staff satisfaction.      

Key results and conclusions of the study include:
  • Prior to implementation, a retained surgical sponge occurred at the institution on average every 64 days. During the study, 87,404 procedures were performed over 18 months using 1,862,373 Safety-Sponges®, and none were retained.  
  • Use of the Safety-Sponge® System caused no workflow disruption or increase in case duration.
  • Staff satisfaction with the Safety-Sponge® System was acceptable with a high degree of trust in the system.
  • The Safety-Sponge® System was found to be highly reliable and cost-effective.

"To my knowledge this is by far the most extensive study ever performed on this important patient safety issue, and we are proud to have this comprehensive, independent research validate the SurgiCount Safety-Sponge® System," said Brian E. Stewart, president and chief executive officer of Patient Safety Technologies, the parent company of SurgiCount Medical, and co-inventor of the Safety-Sponge® System.

The SurgiCount Safety-Sponge® System is a complete sponge counting and documentation system shown to help prevent the occurrence of retained sponges by assuring a more accurate accounting of those items before and after surgery. By labeling each sponge with a unique identifier, the system helps to prevent users from incorrectly counting the individual sponges and unintentionally leaving one inside the patient. The system is currently used in more than 65 government, teaching and community hospitals across the U.S., including five of the 14 "Honor Roll Hospitals" for 2010-2011, as cited by U.S. News and World Report.

"Avoidable medical errors cost the U.S. health care industry an estimated $20 billion every year and put patient lives in jeopardy(1)," said Lisa Ashby, president, Category Management for the Medical Segment of Cardinal Health. "We work continuously with partners like SurgiCount to connect our customers to innovative, cost-effective solutions that help reduce errors and increase the quality of care, and these results confirm that we're making a positive impact on the future of health care."

The Safety-Sponge® System is a proprietary product provided by SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies (OTC Bulletin Board: PSTX), and distributed by Cardinal Health (NYSE: CAH).

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs